These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 435123)

  • 1. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
    Chirito E; Lister C; Chang TM
    Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosinase immobilized within artificial cells for detoxification in liver failure: II. In vivo studies in fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1981 Mar; 4(2):82-5. PubMed ID: 6792085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of homologous cross-circulation and in situ liver perfusion on fulminant hepatic failure rats.
    Mohsini K; Lister C; Chang TM
    Artif Organs; 1980 Aug; 4(3):171-5. PubMed ID: 7417030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternations of liver pathophysiology in experimental hepatic failure treated by two forms of plasma purification procedure.
    Ouchi K; Okabe K; Asanuma Y; Koyama K; Sato T
    Tohoku J Exp Med; 1985 Jun; 146(2):211-23. PubMed ID: 4024095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review.
    Chang TM
    Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 8. [New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals].
    Omori Y
    Nihon Geka Gakkai Zasshi; 1985 May; 86(5):566-75. PubMed ID: 4021990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of homologous plasma cross-circulation on liver function in galactosamine-induced hepatic necrosis in rats.
    Ouchi K; Okabe K; Asanuma Y; Koyama K; Sato T
    Artif Organs; 1984 May; 8(2):179-85. PubMed ID: 6732545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of artificial liver support.
    Williams R; Ede R; Hughes R
    Int J Clin Pharmacol Res; 1985; 5(6):381-7. PubMed ID: 3005180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulated hepatocytes for bioartificial liver support.
    Cai ZH; Shi ZQ; O'Shea GM; Sun AM
    Artif Organs; 1988 Oct; 12(5):388-93. PubMed ID: 3056346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil adherence during hemoperfusion in fulminant hepatic failure.
    Altin M; Hughes RD; Williams R
    Int J Artif Organs; 1982 Sep; 5(5):315-7. PubMed ID: 7174138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoperfusion and DNA synthesis in the rat liver. Part I: the effect of hemoperfusion on the rate of DNA synthesis.
    Ryan CJ; Courtney JM; Wood CB; Blumgart LH
    Artif Organs; 1982 May; 6(2):175-81. PubMed ID: 7125960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-circulation in experimental hepatic failure in the pig.
    Tønnesen K
    Liver; 1986 Oct; 6(5):262-7. PubMed ID: 3784780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term cross-circulation on galactosamine induced hepatic failure rats].
    Okabe K; Koyama K; Ouchi K; Asanuma Y; Sato T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):445-51. PubMed ID: 6749112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats.
    Shnyra A; Bocharov A; Bochkova N; Spirov V
    Artif Organs; 1991 Jun; 15(3):189-97. PubMed ID: 1867529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
    Tabata Y; Chang TM
    Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic scintiscanning in fulminant hepatic failure.
    Murray-Lyon IM; Davidson AR; Rake MO; Osborn SB; Williams R
    Br J Radiol; 1973 Jan; 46(541):30-3. PubMed ID: 4683327
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats.
    Luo J; Zhang Y; Hu X; Zhong S; Chen G; Wang Y; Lin W; Yi C; Zhu H
    J Ethnopharmacol; 2015 Feb; 161():53-9. PubMed ID: 25499312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of Isodon lophanthoides on acute hepatic injury induced by D-galactosamine in rats].
    Hou SZ; Nagao Y; Ye MR; Zhu CC; Li G; Lai XP
    Zhong Yao Cai; 2008 Feb; 31(2):248-50. PubMed ID: 18619271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.